Clinical Trial Update: Hydroxycobalamin and Rural Emergency Medical Services Cyanide Exposure Patients: A Cost Analysis

View source ↗

Summary

A clinical trial examining hydroxocobalamin for cyanide exposure in rural emergency medical services has been withdrawn, with a focus on cost analysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cyanide Poisoning

Drugs mentioned

• Hydroxocobalamin (Hydroxocobalamin)

Snippet

Sponsor: MaineHealth | Conditions: Cyanide Poisoning | Status: WITHDRAWN